We observed a significant enrichment of downregulated transcripts in SRSF2mt AML and FBXO11-knockout MDS-L cells, and conclude that loss of FBXO11 expression may promote MDS transformation with a similar mechanism to SRSF2 mutations (Supplemental Fig. S2B). The gene discussed is SRSF2; the disease is myelodysplastic syndrome.